logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Patel, Bemal
    Director born in September 1973
    Individual (110 offsprings)
    Officer
    icon of calendar 2015-04-21 ~ now
    OF - Director → CIF 0
    Mr Bemal Patel
    Born in September 1973
    Individual (110 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

PHARMACLARITY LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Average Number of Employees
12023-04-01 ~ 2024-03-31
12022-04-01 ~ 2023-03-31
Intangible Assets
4,750 GBP2024-03-31
19,861 GBP2023-03-31
Fixed Assets
4,750 GBP2024-03-31
19,861 GBP2023-03-31
Debtors
Current
570,189 GBP2024-03-31
613,249 GBP2023-03-31
Cash at bank and in hand
24,880 GBP2024-03-31
2,156 GBP2023-03-31
Current Assets
595,069 GBP2024-03-31
615,405 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
-1,110,876 GBP2024-03-31
Net Current Assets/Liabilities
-515,807 GBP2024-03-31
-503,532 GBP2023-03-31
Total Assets Less Current Liabilities
-511,057 GBP2024-03-31
-483,671 GBP2023-03-31
Net Assets/Liabilities
-511,057 GBP2024-03-31
-483,671 GBP2023-03-31
Equity
Called up share capital
2 GBP2024-03-31
2 GBP2023-03-31
Retained earnings (accumulated losses)
-511,059 GBP2024-03-31
-483,673 GBP2023-03-31
Equity
-511,057 GBP2024-03-31
-483,671 GBP2023-03-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
477,669 GBP2024-03-31
477,669 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
472,919 GBP2024-03-31
457,808 GBP2023-03-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
4,750 GBP2024-03-31
19,861 GBP2023-03-31
Other Debtors
Current
570,189 GBP2024-03-31
613,249 GBP2023-03-31
Cash and Cash Equivalents
24,880 GBP2024-03-31
2,156 GBP2023-03-31
Other Creditors
Current
1,110,876 GBP2024-03-31
1,117,937 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
1,000 GBP2023-03-31
Creditors
Current
1,110,876 GBP2024-03-31
1,118,937 GBP2023-03-31

  • PHARMACLARITY LIMITED
    Info
    Registered number 09552359
    icon of addressAmbe House, Commerce Way, Edenbridge, Kent TN8 6ED
    Private Limited Company incorporated on 2015-04-21 (10 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-21
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 26 August 2025 and licensed under the Open Government Licence v3.0.